Table 3. Factors Associated with Non-Culprit Lesion Progression Identified by Logistic Regression Analysis.
| Univariate | Multivariate* | |||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| LDL2 | 5.191 (2.382–11.313) | < 0.001* | 6.832 (2.103–22.200) | 0.001* |
| LAP | 17.136 (6.170–47.592) | < 0.001* | 7.311 (1.242–43.028) | 0.028* |
| STEMI | 7.897 (3.126–19.951) | < 0.001* | 5.855 (1.391–24.635) | 0.016* |
| PR | 7.625 (2.812–20.676) | < 0.001* | 1.718 – |
0.578 |
| EAT | 1.027 (1.014–1.039) | < 0.001* | 1.015 (1.000–1.029) | 0.044* |
CI and adjusted OR was obtained after controlling for age, sex, BMI, hypertension, hyperlipidemia, diabetes mellitus, family history of CAD, history of medications by logistic regression analysis. *p < 0.05. BMI = body mass index, CI = confidence interval, EAT = epicardial adipose tissue, LAP = low attenuation plaque, LDL2 = follow-up low-density lipoprotein cholesterol, OR = odds ratio, PR = positive remodeling, STEMI = ST-elevation myocardial infarction